Depending on their concentration oxidized low density lipoproteins stimulate extracellular matrix synthesis or induce apoptosis in human coronary artery smooth muscle cells

Clinical Chemistry and Laboratory Medicine

Volumn 37, Issue 3, 1999, Pages 319-326

  Bachem, Max G ^a,b   Wendelin, Daniela ^a   Schneiderhan, Wilhelm ^a   Haug, Cornelia ^a   Zorn, Ulrike ^a   Gross, Hans J ^a   Schmid Kotsas, Alexandra ^a   Grünert, Adolf ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Annexin V; APO 2.7; Apoptosis; Collagen synthesis; Fibronectin synthesis; Oxidized low density lipoproteins (oxLDL); Smooth muscle cells; TUNEL assay

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; CATALASE; COLLAGEN TYPE 1; FAS ANTIGEN; FIBRONECTIN; HYDROGEN PEROXIDE; LIPOCORTIN 5; MALONALDEHYDE; OXIDIZED LOW DENSITY LIPOPROTEIN; PROBUCOL; SCAVENGER; TROLOX C;

ANTIGEN EXPRESSION; APOPTOSIS; ATHEROSCLEROSIS; CELL STIMULATION; COLLAGEN SYNTHESIS; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY ARTERY; CYTOTOXICITY; DNA NICK TRANSLATION; EXTRACELLULAR MATRIX; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; ISCHEMIC HEART DISEASE; OXIDATIVE STRESS; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; STATISTICAL ANALYSIS;

LETHRINIDAE;

EID: 0032944098     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.1999.054     Document Type: Conference Paper

References (43)

1. Poli G, Parola M. Oxidative damage and fibrogenesis. Free Radic Biol Med 1997; 22:287-305.
2. Halliwell B. The role of oxygen radicals in human disease, with particular reference to the vascular system. Haemostasis 1993; 23 Suppl 1:118-26.
3. Steinberg D, Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis. Circulation 1997; 95:1062-71.
4. Esterbauer H, Ramos P. Chemistry and pathophysiology of oxidation of LDL. Rev Physiol Biochem Pharmacol 1996; 127:31-64.
5. Penn MS, Chisolm GM. Oxidized lipoproteins, altered cell function and atherosclerosis. Atherosclerosis 1994; 108 (-Suppl.):S21-S9.
6. Yla-Herttuala S, Palinsky W, Rosenfeld ME, Steinberg D, Witzum JL. Lipoproteins in normal and atherosclerotic aorta. Eur Heart J 1990; 11 (Suppl. E):88-9.
7. Freeman MW. Scavenger receptors in atherosclerosis. Curr Opin Hematol 1997; 4:41-7.
8. Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 1993; 268:11811-6.
9. Lipsky RH, Eckert DM, Tang Y, Ockenhouse CF. The carboxyl-terminal cytoplasmic domain of CD36 is required for oxidized low-density lipoprotein modulation of NF-kappaB activity by tumor necrosis factor-alpha. Recept Signal Transduct 1997; 7:1-11.
10. Jürgens G, Chen Q, Ledinski G, Kager G, Hammer A, Esterbauer H. Oxidierte lipoproteine und Atherogenese. Acta Med Austriaca 1993; 20:85-89.
11. Nagy L, Tontonoz P, Alvarez JG, Chen H, Evans RM. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 1998; 93: 229-40.
12. Coffey MD, Cole RA, Colles SM, Chisolm GM. In vitro cell injury by oxidized low density lipoprotein involves lipid hydroperoxide-induced formation of alkoxyl, lipid, and peroxyl radicals. J Clin Invest 1995; 96:1866-73.
13. Heery JM, Kozak M, Stafforini DM, Jones DA, Zimmerman GA, McIntyre TM, et al. Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells. J Clin Invest 1995; 96:2322-30.
14. Natarajan V, Scribner WM, Hart CM, Parthasarathy S. Oxidized low density lipoprotein-mediated activation of phospholipase D in smooth muscle cells: a possible role in cell proliferation and atherogenesis. J Lipid Res 1995; 6:2005-16.
15. Lee HS, Kim BC, Kim YS, Choi KH, Chung HK. Involvement of oxidation in LDL-induced collagen gene regulation in mesangial cells. Kidney Int 1996; 50:1582-90.
16. Daugherty A, Roselaar SE. Lipoprotein oxidation as a mediator of atherogenesis: insights from pharmacological studies. Cardiovasc Res 1995;29:297-311.
17. Jimi S, Saku K, Uesugi N, Sakata N, Takebayashi S. Oxidized low density lipoprotein stimulates collagen production in cultured arterial smooth muscle cells. Atherosclerosis 1995; 116:15-26.
18. Ding G, van Goor H, Ricardo SD, Orlowski JM, Diamond JR. Oxidized LDL stimulates the expression of TGF-beta and fibronectin in human glomerular epithelial cells. Kidney Int 1997; 51:147-54.
19. Havel R, Eder H, Bragndon J. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955; 34:1345-53.
20. Haberland ME, Fogelman AM, Edwards PA. Specificity of receptor-mediated recognition of malondialdehyde-modified low density lipoproteins. Proc Natl Acad Sci USA 1982; 79:1712-6.
21. Bachem MG, Schneider E, Groß H, Weidenbach H, Schmid RM, Menke A, et al. Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology 1998; 115:421-32.
22. Westhuyzen J. The oxidation hypothesis of atherosclerosis: an update. Ann Clin Lab Sci 1997; 27:1-10.
23. Nenseter MS, Drevon CA. Dietary polyunsaturates and peroxidation of low density lipoprotein. Curr Opin Lipidol 1996; 7:8-13.
24. Araujo JA, Romano EL, Brito BE, Parthe V, Romano M, Bracho M, et al. Iron overload augments the development of atherosclerotic lesions in rabbits. Arterioscler Thromb Vasc Biol 1995; 15:1172-80.
25. Esterbauer H, Gebicki J, Punl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 1992; 13:341-90.
26. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 1997; 272:20963-6.
27. Rice EC, Burdon R. Free radical-lipid interactions and their pathological consequences. Prog Lipid Res 1993; 32:71-110.
28. Cohen JJ. Apoptosis: the physiologic pathway of cell death. Hosp Pract 1993; 15:35-43.
29. Villa P, Kaufmann SH, Earnshaw WC. Caspases and caspase inhibitors. Trends Biochem Sei 1997; 22:388-93.
30. Darzynkiewicz Z, Juan G, Li X, Gorczyca W, Murakami T, Traganos F. Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis). Cytometry 1997; 27:1-20.
31. Zhang C, Ao Z, Seth A, Schlossman SF. A mitochondrial membrane protein defined by a novel monoclonal antibody is preferentially detected in apoptotic cells. J Immunol 1996; 157:3980-7.
32. Koester SK, Roth P, Mikulka WR, Schlossman SF, Zhang C, Bolton WE. Monitoring early cellular responses in apoptosis is aided by the mitochondrial membrane protein-specific monoclonal antibody APO2.7. Cytometry 1997; 29:306-12.
33. van den Eijnde SM, Luijsterburg AJ, Bohart L, De Zeeuw, van Dierendonck JH, Reutelingsperger CP, et al. In situ detection of apoptosis during embryogenesis with Annexin V: from whole mount to ultrastructure. Cytometry 1997; 29:313-20.
34. van Engeland M, Nieland LJ, Ramaekers FC, Schutte B, Reutelingsperger CP. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 1998; 31:1-9.
35. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119:493-501.
36. Mori H. Programmed cell death in the integral tissue of the fetal mouse limb is apoptosis with DNA fragmentation. Anatom Rec 1995; 242:103-10.
37. Parola M, Pinzani M, Casini A, Albano E, Poli G, Gentilini A, et al. Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen α1 (I) gene expression in human liver fat-storing cells. Biochem Biophys Res Commun 1993; 176:1044-50.
38. Marx N, Schönbeck U, Lazar MA, Libby P, Plutzky J. Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells. Circ Res 1998; 83:1097-103.
39. Galis Z, Sukhova G, Lark M, Libby P. Increased expresssion of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994; 94:2493-503.
40. Jovinge S, Ares MP, Kallin B, Nilsson J. Human monocytes/macrophages release TNF-alpha in response to oxLDL. ArteriosclerThromb Vase Biol 1996; 16:1573-9.
41. Erl W, Weber PC, Weber C. Monocytic cell adhesion to endothelial cells stimulated by oxidized low density lipoprotein is mediated by distinct endothelial ligands. Atherosclerosis 1998; 136:297-303.
42. Weber C, Erl W, Weber PC. Enhancement of monocyte adhesion to endothelial cells by oxidatively modified low-density lipoprotein is mediated by activation of CD11b. Biochem Biophys Res Commun 1995; 206:621-8.
43. Lehr HA, Backer M, Marklund SL, Hübner C, Arfors KE, Kohlschüüter A, et al. Superoxide-dependent stimulation of leukocyte adhesion by oxidatively modified LDL in vivo. Arterioscler Thromb 1992; 12:824-9.